title: Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.
abstract: Cystic fibrosis females have a worse prognosis compared to male patients. Furthermore, cystic fibrosis patients infected with Pseudomonas aeruginosa have been shown to have dysregulated cytokine profiles, as higher levels of tumour necrosis factor alpha (TNF-alpha), interleukin (IL)-8, and lower levels of IL-10 are found in the bronchoalveolar lavage fluid compared to healthy controls. The present study was aimed at investigating the importance of gender and IL-10 in the susceptibility of C57BL/6 mice to pulmonary infection with Pseudomonas aeruginosa. We found that wildtype females were more susceptible than males to infection, as we observed greater weight loss, higher bacterial load, and inflammatory mediators in their lungs. IL-10 knockout mice, both females and males, had higher levels of TNF-alpha in the lungs compared to wildtype mice and maintained higher levels of polymorphonuclear cells and lower levels of macrophages for a longer period of time. Our results demonstrate that the number of bacteria recovered from the lungs of IL-10 knockout male mice was significantly higher than that observed in their wildtype male counterparts and we show that neutralization of IL-10 in infected female mice for a prolonged period of time leads to increased susceptibility to infection. Results reported in this study clearly demonstrate that females, both wildtype and IL-10 knockout mice are more susceptible to Pseudomonas aeruginosa infection than males, and that they mount a stronger inflammatory response in the lungs.
authors.affiliation: Departments of Experimental Medicine and Urology, McGill University Health Center, Montreal General Hospital Research Institute, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada.
authors.forename: Claudine
authors.initials: C
authors.lastname: Guilbault
authors.forename: Peter
authors.initials: P
authors.lastname: Stotland
authors.forename: Claude
authors.initials: C
authors.lastname: Lachance
authors.forename: Mifong
authors.initials: M
authors.lastname: Tam
authors.forename: Anna
authors.initials: A
authors.lastname: Keller
authors.forename: Luann
authors.initials: L
authors.lastname: Thompson-Snipes
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Cowley
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Hamilton
authors.forename: David H
authors.initials: DH
authors.lastname: Eidelman
authors.forename: Mary M
authors.initials: MM
authors.lastname: Stevenson
authors.forename: Danuta
authors.initials: D
authors.lastname: Radzioch
mesh_terms: D000818:Animals; D001835:Body Weight; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D018450:Disease Progression; D004198:Disease Susceptibility / Q000276:immunology; D005260:Female; D016753:Interleukin-10 / Q000172:deficiency* / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000382:microbiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011552:Pseudomonas Infections / Q000276:immunology* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D012141:Respiratory Tract Infections / Q000276:immunology* / Q000382:microbiology; D012737:Sex Factors; D015996:Survival Rate; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10